Compare BTMD & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | SACH |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.0M | 38.4M |
| IPO Year | 2021 | 2016 |
| Metric | BTMD | SACH |
|---|---|---|
| Price | $1.10 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $2.61 | N/A |
| AVG Volume (30 Days) | 123.7K | ★ 169.7K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 22.73% |
| EPS Growth | ★ 722.22 | 104.30 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $192,219,000.00 | $57,500,000.00 |
| Revenue This Year | N/A | $94.91 |
| Revenue Next Year | $5.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $0.76 |
| 52 Week High | $3.26 | $1.45 |
| Indicator | BTMD | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 27.63 | 43.17 |
| Support Level | N/A | $0.77 |
| Resistance Level | $1.68 | $0.99 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 1.52 | 12.40 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.